New familial cases of karyomegalic interstitial nephritis with mutations in the FAN1 gene.
Chronic tubulointerstitial nephritis
FAN1 gene
Frameshift variants
Karyomegalic interstitial nephritis
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
14 06 2021
14 06 2021
Historique:
received:
01
10
2020
accepted:
07
06
2021
entrez:
15
6
2021
pubmed:
16
6
2021
medline:
20
1
2022
Statut:
epublish
Résumé
Karyomegalic interstitial nephritis (KIN) is a rare disease entity first described by Burry in 1974. The term KIN was introduced by Mihatsch et al. in 1979. KIN is characterized by chronic tubulointerstitial nephritis associated with enlarged tubular epithelial cell nuclei, which leads to a progressive decline of renal function. The prevalence of this disease is less than 1% of all biopsies, and its pathogenesis is unclear. KIN results from mutations in FAN1 (FANCD2/FANCI-Associated Nuclease 1), a gene involved in the DNA damage response pathway, particularly in the kidney. In this study, we report two Tunisian consanguineous families with KIN caused by mutations in the FAN1 gene. Direct sequencing of the coding regions and flanking intronic sequences of the FAN1 gene was performed in three affected members. Three prediction programs (Polyphen-2 software, SIFT, and MutationTaster) were used to predict the functional effect of the detected variations. Two causative frameshift variants in the FAN1 gene were identified in each family: The previously described frameshift mutation c.2616delA (p.Asp873ThrfsTer17) and a novel mutation c.2603delT (p.Leu868ArgfsTer22) classified as "pathogenic" according to the American College of Medical Genetics and Genomics (ACMG) guidelines. To our best knowledge, this is the first Tunisian study involving familial cases of KIN with mutations in the FAN1 gene. We hypothesize that these findings can expand the mutational spectrum of KIN and provide valuable information on the genetic cause of KIN.
Sections du résumé
BACKGROUND
Karyomegalic interstitial nephritis (KIN) is a rare disease entity first described by Burry in 1974. The term KIN was introduced by Mihatsch et al. in 1979. KIN is characterized by chronic tubulointerstitial nephritis associated with enlarged tubular epithelial cell nuclei, which leads to a progressive decline of renal function. The prevalence of this disease is less than 1% of all biopsies, and its pathogenesis is unclear. KIN results from mutations in FAN1 (FANCD2/FANCI-Associated Nuclease 1), a gene involved in the DNA damage response pathway, particularly in the kidney. In this study, we report two Tunisian consanguineous families with KIN caused by mutations in the FAN1 gene.
METHODS
Direct sequencing of the coding regions and flanking intronic sequences of the FAN1 gene was performed in three affected members. Three prediction programs (Polyphen-2 software, SIFT, and MutationTaster) were used to predict the functional effect of the detected variations.
RESULTS
Two causative frameshift variants in the FAN1 gene were identified in each family: The previously described frameshift mutation c.2616delA (p.Asp873ThrfsTer17) and a novel mutation c.2603delT (p.Leu868ArgfsTer22) classified as "pathogenic" according to the American College of Medical Genetics and Genomics (ACMG) guidelines.
CONCLUSION
To our best knowledge, this is the first Tunisian study involving familial cases of KIN with mutations in the FAN1 gene. We hypothesize that these findings can expand the mutational spectrum of KIN and provide valuable information on the genetic cause of KIN.
Identifiants
pubmed: 34126972
doi: 10.1186/s12920-021-01009-7
pii: 10.1186/s12920-021-01009-7
pmc: PMC8201669
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160Références
Indian J Nephrol. 2020 Jul-Aug;30(4):283-285
pubmed: 33273795
Medicine (Baltimore). 2016 May;95(20):e3349
pubmed: 27196444
BMC Nephrol. 2020 Mar 27;21(1):107
pubmed: 32220227
Ann Med Interne (Paris). 1998 Sep;149(5):291-4
pubmed: 9791564
Science. 2010 Aug 6;329(5992):693-6
pubmed: 20671156
Cell. 2012 Aug 3;150(3):533-48
pubmed: 22863007
Nat Genet. 2012 Jul 08;44(8):910-5
pubmed: 22772369
BMC Nephrol. 2020 Feb 28;21(1):74
pubmed: 32111193
Diagn Cytopathol. 2007 Mar;35(3):179-82
pubmed: 17304531
Cell. 2010 Jul 9;142(1):77-88
pubmed: 20603016
Clin Nephrol. 1979 Aug;12(2):54-62
pubmed: 527271
Mol Cell. 2010 Jul 9;39(1):36-47
pubmed: 20603073
Cell. 2010 Jul 9;142(1):65-76
pubmed: 20603015
Genes Dev. 2016 Mar 15;30(6):639-44
pubmed: 26980188
J Pathol. 1974 Jul;113(3):147-50
pubmed: 4372331